ARTICLE | Company News
Sinclair IS Pharma, Hikma Pharmaceuticals sales and marketing update
March 25, 2013 7:00 AM UTC
Under a 10-year deal, Sinclair granted Hikma exclusive rights to commercialize Flammacerium in 18 countries within the Middle East and North Africa region. The first launches are expected in late 201...